The implications of myelodysplastic syndrome - associated chromosomal abnormalities in the development of graft-versus-host disease

European Journal of Haematology

Volumn 90, Issue 6, 2013, Pages 525-530

  Arai, Yasuyuki ^a   Yamashita, Kouhei ^a   Mizugishi, Kiyomi ^a   Takaori Kondo, Akifumi ^a   Chiba, Tsutomu ^a   Watanabe, Tomohiro ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cytokine; Graft versus host disease; Host derived antigen presenting cells; Myelodysplastic syndrome; Trisomy 8 and der(1; 7)(q10; p10)

Indexed keywords

BUSULFAN; CD14 ANTIGEN; CHLORDANE; FLUDARABINE; INTERLEUKIN 10; MELPHALAN; METHOTREXATE; STEROID; TACROLIMUS; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ADULT; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD EXAMINATION; CASE REPORT; CAUSE OF DEATH; CELL DEATH; CELL SURVIVAL; COMPARATIVE STUDY; CONSOLIDATION CHEMOTHERAPY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DIARRHEA; DISEASE COURSE; DYSPLASIA; DYSPNEA; ENTERITIS; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; HYPOXIA; LUNG LAVAGE; LYMPHOCYTOSIS; MACROPHAGE; MALE; MONOCYTE; MYELODYSPLASTIC SYNDROME; NK T CELL LYMPHOMA; PANCYTOPENIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION DOSE DISTRIBUTION; REDUCED INTENSITY CONDITIONING; REFRACTORY ANEMIA; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; TRISOMY 8;

ADULT; APOPTOSIS; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-10; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; SKIN DISEASES; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TRISOMY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878151676     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12100     Document Type: Article

References (18)

1. Bejar R, Levine R, Ebert BL. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J Clin Oncol 2011;29:504-15.
2. Pedersen B, Norgaard JM, Pedersen BB, Clausen N, Rasmussen IH, Thorling K. Many unbalanced translocations show duplication of a translocation participant. Clinical and cytogenetic implications in myeloid hematologic malignancies. Am J Hematol 2000;64:161-9.
3. Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med 2009;361:1872-85.
4. Kawabata H, Sawaki T, Kawanami T, et al. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med 2006;45:1309-14.
5. Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M. Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis - Behcet's syndrome. Leuk Lymphoma 2001;42:115-21.
6. Nakamura F, Watanabe T, Hori K, Ohara Y, Yamashita K, Tsuji Y, Ueda Y, Mikami S, Nakase H, Chiba T. Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells. Digestion 2009;79:215-9.
7. Zeiser R, Penack O, Holler E, Idzko M. Danger signals activating innate immunity in graft-versus-host disease. J Mol Med (Berl) 2011;89:833-45.
8. Haniffa M, Ginhoux F, Wang XN, et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. J Exp Med 2009;206:371-85.
9. Nishiwaki S, Terakura S, Ito M, et al. Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease. Blood 2009;114:3113-6.
10. Watanabe T, Chiba T. Defective interleukin-10 signaling in human inflammatory bowel disease. Gastroenterology 2010;138:2016-8.
11. Watanabe T, Kudo M, Chiba T, Wakatsuki Y. Molecular mechanisms of portal vein tolerance. Hepatol Res 2008;38:441-9.
12. Watanabe T, Katsukura H, Shirai Y, Yamori M, Nishi T, Chiba T, Kita T, Wakatsuki Y. A liver tolerates a portal antigen by generating CD11c+ cells, which select Fas ligand+ Th2 cells via apoptosis. Hepatology 2003;38:403-12.
13. Chen G, Zeng W, Miyazato A, Billings E, Maciejewski JP, Kajigaya S, Sloand EM, Young NS. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood 2004;104:4210-8.
14. Das R, Chen X, Komorowski R, Hessner MJ, Drobyski WR. Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease. Blood 2009;113:2352-62.
15. Matte CC, Liu J, Cormier J, Anderson BE, Athanasiadis I, Jain D, McNiff J, Shlomchik WD. Donor APCs are required for maximal GVHD but not for GVL. Nat Med 2004;10:987-92.
16. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, Shlomchik MJ, Emerson SG. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999;285:412-5.
17. Zhang Y, Shlomchik WD, Joe G, Louboutin JP, Zhu J, Rivera A, Giannola D, Emerson SG. APCs in the liver and spleen recruit activated allogeneic CD8 + T cells to elicit hepatic graft-versus-host disease. J Immunol 2002;169:7111-8.
18. Heimesaat MM, Nogai A, Bereswill S, et al. MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 2010;59:1079-87.